Stocks › CTTH
CTT PHARMACEUTICAL HOLDINGS, INC.
CTTH·OTC·
United States·USD
United States·USD$0.06
+0.00 (+0.00%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. · OTC
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CTTHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CTTH by members of U.S. Congress · 0 on record
No congressional trades in CTTH on record.
Whale Activity
Institutional 13F positions
No 13F positions in CTTH among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CTTH insiders, by quarter · Form 4
Recent Insider Transactions
67 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO · Director | Purchase | +3,700 | $0.06 | $204 | Oct 6, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO · Director | Purchase | +3,400 | $0.06 | $187 | Sep 28, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO · Director | Purchase Amended | +10.1K | $0.04 | $455 | Sep 22, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO · Director | Purchase | +10.1K | $0.04 | $455 | Sep 22, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO · Director | Purchase | +10.9K | $0.05 | $523 | Sep 16, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +3,500 | $0.05 | $175 | Sep 10, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +9,800 | n/c | — | Sep 4, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +3,000 | $0.05 | $147 | Sep 2, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +3,500 | $0.05 | $172 | Aug 31, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +2,100 | $0.06 | $116 | Aug 24, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +11.5K | $0.04 | $518 | Aug 20, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +10.0K | $0.06 | $590 | Aug 19, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +1,800 | $0.06 | $112 | Aug 14, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +7,700 | $0.07 | $501 | Aug 7, 2026 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +8,300 | $0.06 | $498 | Dec 17, 2025 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.Director | Purchase | +200.0K | $0.04 | $8K | Nov 20, 2025 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +62.9K | $0.04 | $3K | Nov 20, 2025 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +7,000 | $0.06 | $420 | Oct 31, 2025 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +6,815 | n/c | — | Sep 23, 2025 | Form 4 ↗ |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Purchase | +44.1K | $0.05 | $2K | Aug 2, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CTTH · SEC Form N-PORT
Funds report their holdings by CUSIP, and CTTH could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CTT PHARMACEUTICAL HOLDINGS, INC. as client
No lobbying filings found naming CTT PHARMACEUTICAL HOLDINGS, INC. as the client.
Government Contracts
Federal awards to CTT PHARMACEUTICAL HOLDINGS, INC. · USAspending
No federal contract awards found for CTT PHARMACEUTICAL HOLDINGS, INC..
U.S. Patents
Recent USPTO applications naming CTT PHARMACEUTICAL HOLDINGS, INC.
No USPTO patent applications found for CTT PHARMACEUTICAL HOLDINGS, INC..
Annual Financials
From CTTH's 10-K filings · XBRL
No annual XBRL figures on record for CTTH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CTTH's price history.
About CTT PHARMACEUTICAL HOLDINGS, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTAMPA, FL
IncorporatedFL
SEC CIK0001035422 ↗
Former namesMindesta Inc., INDUSTRIAL MINERALS INC, PNW CAPITAL INC